1. Interaction between amphetamine and monoamine oxidase inhibitors
- Author
-
Kerin O'Dea and Michael J. Rand
- Subjects
Male ,Isocarboxazid ,Monoamine Oxidase Inhibitors ,Monoamine oxidase ,Pharmacology ,Mice ,Sex Factors ,Phenelzine ,medicine ,Animals ,Amphetamine ,Chemistry ,Tranylcypromine ,Drug Synergism ,Pargyline ,Hydrazines ,Nialamide ,Female ,Monoamine oxidase B ,Mebanazine ,medicine.drug - Abstract
Observations were made on the acute toxicities in mice of amphetamine and of the monoamine oxidase inhibitors isocarboxazid, mebanazine, nialamide, pargyline, phenelzine and tranylcypromine, with determination of the LD 50 values. Then, the effect of pretreatment of mice with monoamine oxidase inhibitors, or pretreatment with amphetamine, on the LD 50 of amphetamine was determined. The degree of potentiation of amphetamine toxicity by monoamine oxidase inhibitors varied from one to another, the range being from pargyline, which increased the toxicity of amphetamine about 3-fold, to mebanazine which increased it about 100-fold. There was no correlation between the toxicities of the monoamine oxidase inhibitors in mice and the degree to which they potentiated the toxicity of amphetamine. Amphetamine pretreatment was found to have no effect on its own toxicity, determined subsequently.
- Published
- 1969